IIM
PCRX icon

INTECH Investment Management’s Pacira BioSciences PCRX Stock Holding History

INTECH Investment Management’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$702K Sell
31,061
-135,654
-81% -$3.01M 0.01% 1176
2025
Q4 		$4.31M Buy
166,715
+103,593
+164% +$2.46M 0.04% 426
2025
Q3 		$1.63M Buy
63,122
+41,137
+187% +$1.01M 0.01% 890
2025
Q2 		$525K Hold
21,985
– – ﹤0.01% 1586
2025
Q1 		$546K Buy
21,985
+5,018
+30% +$120K 0.01% 1561
2024
Q4 		$320K Buy
16,967
+4,251
+33% +$74.6K ﹤0.01% 1808
2024
Q3 		$191K Buy
+12,716
New +$217K ﹤0.01% 1743

Other funds holding PCRX

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
DPCM
Doma Perpetual Capital Management Miami, Florida $372M AUM 14.96% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return